Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03062800
Recruitment Status : Recruiting
First Posted : February 23, 2017
Last Update Posted : June 5, 2019
Sponsor:
Information provided by (Responsible Party):
Qilu Hospital of Shandong University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : November 2021
Publications: